Merck KGaA designs new agent with good neuroleptic activity, low liability for side effects May 3, 1999
Patent provides Cortex exclusive use of AMPA receptor modulators for improving memory, cognition April 30, 1999
Open-label trial demonstrates efficacy of gabapentin monotherapy in AIDS-related neuropathy April 29, 1999
RSS